UM Researcher Lizza Hendriks appointed member of The Young Academy
In 2021, Lizza Hendriks, Assistant Professor at research institute GROW, School for Oncology and Developmental Biology of Maastricht University will join The Young Academy. This is a platform of the Royal Netherlands Academy of Sciences, where young top scientists from different disciplines work together in the field of research and science policy.
Dr Lizza Hendriks (1981) has worked at Maastricht UMC + as a lung specialist since 2012. Her focus area is thoracic oncology, in particular prevention and optimal treatment of brain metastases in lung cancer. In 2017, she earned her PhD on this topic. To gain in-depth knowledge of both research and medical oncology, she worked one year as a postdoc at the Gustave Roussy Institute in France.
Since 2019, Dr Hendriks has coordinated the clinical lung cancer research of the lung diseases department in Maastricht. She does this in addition to her clinical tasks and teaching. Currently, Dr Hendriks supervises six PhD students.
Her research ambition is to develop personalised therapy (in terms of biomarkers and psychosocial and cognitive capacity) with a focus on prevention/optimal treatment of brain metastases, while preserving neurocognition. To achieve this, immunotherapy, targeted therapy and radiotherapy are applied, including the use of advanced imaging analysis techniques such as radiomics.
Dr Hendriks received several abstract awards as well as the Dirkje Postma Talent Award (incentive subsidy for her own research line) in 2019. She is (co-)author of more than 80 peer-reviewed articles.
The Young Academy
The Young Academy consists of talented researchers who share a broad interest in scientific practice, science policy and science communication. The Young Academy is an independent body within the Royal Netherlands Academy of Sciences. Membership lasts for five years.
Within De Jonge Akademie, Lizza Hendriks is particularly committed to early career policy, getting young people interested in and motivated for research. She will also contribute to the new Recognition and Rewards policy, with a focus on policy for physician researchers.
Also read
-
Why some people hesitate to vaccinate and how healthcare can address this
Doubts about vaccination continue to be a significant challenge for global public health. The World Health Organisation (WHO) has listed vaccine hesitancy as one of the top ten threats to global health.
But what exactly is vaccine hesitancy and how does it impact our society? How can we address it...
-
GROW research: all-in-one test for genetic defects in embryos🧪
Researchers at Maastricht UMC+ and GROW have developed a technique that can analyse the entire genome in a single test, allowing for faster determination of embryos suitable for successful pregnancy.
-
Tears reveal more than emotion
With the tear fluid research set up by Marlies Gijs, she is doing groundbreaking work.
